Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation - 05/08/11
, Mohamed Abdel-Wahab, MD a, b, Omar Awad, MD b, Volker Geist, MD a, Ghada El-Shahed, MD b, Reinhard Semmler, MD c, Mazen Tawfik, MD b, Ahmed A. Khattab, MD b, Doreen Richardt, MD d, Gert Richardt, MD a, Ralph Tölg, MD aRiassunto |
Background |
The conventional surgical aortic bioprostheses used for treatment of aortic stenosis (AS) are inherently stenotic in nature. The more favorable mechanical profile of the Medtronic CoreValve bioprosthesis may translate into a better hemodynamic and neurohormonal response.
Patients and Methods |
The early hemodynamic and neurohormonal responses of 56 patients who underwent successful transcatheter aortic valve implantation (TAVI) using the Medtronic CoreValve bioprosthesis for severe symptomatic AS were compared with those of 36 patients who underwent surgical aortic valve replacement (SAVR) using tissue valves in the same period.
Results |
At baseline, patients in the TAVI and SAVR group had comparable indexed aortic valve area (0.33 ± 0.1 vs 0.34 ± 0.1 cm2, respectively; P = .69) and mean transvalvular gradient (51.1 ± 16.5 vs 53.1 ± 14.3 mm Hg, respectively; P = .56). At 30-day follow-up, mean transvalvular gradient was lower in the TAVI group than in the SAVR group (10.3 ± 4 vs 13.1 ± 6.2 mm Hg, respectively; P = .015), and the indexed aortic valve area was larger in the TAVI group (1.0 ± 0.14 vs 0.93 ± 0.13 cm2/m2; P = .017). There was a trend toward a higher incidence of moderate patient-prosthesis mismatch in the surgical group compared with the TAVI group (30.5% vs 17.8%, respectively; P = .11). The overall incidence of prosthetic regurgitation (any degree) was higher in the TAVI group than in the SAVR group (85.7% vs 16.7%, respectively; P < .00001). The left ventricular mass index decreased after TAVI (175.1 ± 61.8 vs 165.6 ± 57.2 g/m2; P = .0003) and remained unchanged after SAVR (165.1 ± 50.6 vs 161 ± 64.8 g/m2; P = .81). Similarly, NT-ProBNP decreased after TAVI (3,479 ± 2,716 vs 2,533 ± 1,849 pg/mL; P = .033) and remained unchanged after SAVR (1,836 ± 2,779 vs 1,689 ± 1,533 pg/mL; P = .78). There was a modest correlation between natriuretic peptides and left ventricular mass index in the whole cohort (r = 0.4, P = .013).
Conclusion |
In patients with severe AS, TAVI resulted in lower transvalvular gradients and higher valve areas than SAVR. Such hemodynamic performance after TAVI may have contributed to early initiation of a reverse cardiac remodeling process and a decrease in natriuretic peptides.
Il testo completo di questo articolo è disponibile in PDF.Mappa
Vol 160 - N° 5
P. 862-869 - Novembre 2010 Ritorno al numero
Articolo precedente
- Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events
- Matthew Sibbald, Andrew T. Yan, Wei Huang, Keith A.A. Fox, Joel M. Gore, Ph. Gabriel Steg, Kim A. Eagle, David Brieger, Gilles Montalescot, Shaun G. Goodman
- Ventricular response to stress predicts outcome in adult patients with a systemic right ventricle
- Michiel M. Winter, Roderick W.C. Scherptong, Sabina Kumar, Berto J. Bouma, Igor I. Tulevski, Laurens F. Tops, Arno A.W. Roest, Hubert W. Vliegen, Albert de Roos, Maarten Groenink, Barbara J.M. Mulder
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?